DLGAP1 — DLG Associated Protein 1

📖 Wiki Page

gene1008 wordssynced 2026-04-02

DLGAP1 — DLG Associated Protein 1

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DLGAP1 — DLG Associated Protein 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DLGAP1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DLGAP1 — DLG Associated Protein 1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=DLGAP1" target="_blank">Search NCBI</a></td>
</tr>
</table>

Dlgap1 — Dlg Associated Protein 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@grip2024]
title: DLGAP1 Gene [@psddlgap2023]
description: DLG Associated Protein 1 gene implicated in neurodegenerative diseases [@dlgap2023]
tags: gene, neurodegeneration [@autismassociated2022]

--- [@transcriptomic2022]

.infobox.inbox-gene [@postsynaptic2021]
DLGAP1 [@therapeutic2021]
=== ===
Full Name: DLG Associated Protein 1
Chromosome: 18p11.31
NCBI Gene ID: 9229
OMIM: 609442
Ensembl ID: ENSG00000170537
UniProt: O75178
=== ===
Associated Diseases: Autism spectrum disorder, schizophrenia, intellectual disability, [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease-disease)

Overview

...

DLGAP1 — DLG Associated Protein 1

Introduction

--- [@transcriptomic2022]

Overview

DLG Associated Protein 1 (DLGAP1), also known as SAPAP1 or DLGAP1, is a critical postsynaptic scaffolding protein that plays essential roles in synaptic organization, plasticity, and signal transduction at excitatory synapses. The gene encodes a member of the SAPAP family of proteins, which are core components of the postsynaptic density (PSD) macromolecular complex. DLGAP1 serves as a molecular bridge between synaptic receptors and downstream signaling molecules, facilitating proper synaptic transmission and plasticity mechanisms fundamental to learning, memory, and cognitive function.

Gene Structure

The DLGAP1 gene spans approximately 25 kb on chromosome 18p11.31 and contains 21 exons encoding a protein of 977 amino acids with a molecular weight of approximately 110 kDa. The gene exhibits complex alternative splicing, producing multiple isoforms with distinct expression patterns and subcellular localizations. The protein contains multiple protein-protein interaction domains, including an N-terminal PDZ-binding motif that mediates interactions with PSD-95 family proteins, as well as coiled-coil domains and proline-rich regions that facilitate binding to various signaling molecules and cytoskeletal proteins.

Protein Structure and Function

DLGAP1 is a core scaffold protein enriched in the postsynaptic density of excitatory synapses, particularly in [dendritic spines](/cell-types/dendritic-spines). The protein organizes into large macromolecular complexes that include PSD-95 (DLG4), SAP97, AMPA receptor subunits, [NMDA](/entities/nmda-receptor) receptor subunits, and various signaling enzymes. DLGAP1 contains multiple PDZ domains that interact with the C-terminal PDZ-binding motifs of target proteins, creating a modular scaffolding platform that coordinates synaptic protein localization and signaling.

The primary functions of DLGAP1 include: (1) anchoring AMPA receptors at the postsynaptic membrane through interactions with GRIP1 and PICK1, enabling proper glutamate receptor trafficking and synaptic plasticity; (2) organizing NMDA receptor signaling complexes that regulate calcium influx and downstream signaling cascades including CaMKII and MAPK pathways; (3) linking synaptic receptors to the actin cytoskeleton through interactions with cortactin and other cytoskeletal proteins, stabilizing dendritic spine morphology; (4) recruiting signaling enzymes including phosphatases, kinases, and Rho GTPase regulators to the postsynaptic membrane.

Expression Pattern

DLGAP1 exhibits high expression in brain regions associated with learning and memory, including the cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus) (CA1-CA3 regions and dentate gyrus), basal ganglia, and cerebellum. Expression is particularly enriched in the postsynaptic densities of excitatory synapses on [dendritic spines](/cell-types/dendritic-spines). The gene is also expressed at lower levels in other tissues including heart, kidney, and testis. During development, DLGAP1 expression increases during synaptogenesis, peaking in adulthood when synaptic plasticity is most robust.

Role in Neurodegeneration

While primarily studied in neurodevelopmental disorders, emerging evidence links DLGAP1 dysfunction to neurodegenerative diseases:

Alzheimer's Disease: DLGAP1 is downregulated in Alzheimer's disease brain tissue, particularly in regions affected by [amyloid-beta](/proteins/amyloid-beta) pathology including the hippocampus and prefrontal cortex. Loss of DLGAP1 expression may contribute to synaptic dysfunction and memory impairment through disruption of AMPA receptor trafficking and NMDA receptor signaling. The protein may also play roles in [tau](/proteins/tau) pathology through interactions with [tau](/proteins/tau) kinases and phosphatases.

Parkinson's Disease: Altered DLGAP1 expression has been observed in Parkinson's disease models and post-mortem brain tissue. The protein's role in dopaminergic synaptic plasticity may be relevant to disease pathogenesis, particularly in striatal synapses where dopaminergic and glutamatergic signaling converge.

Neurodevelopmental Disorders: DLGAP1 mutations and copy number variations are associated with autism spectrum disorder, intellectual disability, and schizophrenia. These neurodevelopmental conditions share features with neurodegenerative processes including synaptic dysfunction and abnormal protein aggregation.

Therapeutic Implications

DLGAP1 represents a potential therapeutic target for neurodegenerative diseases. Strategies under investigation include: (1) small molecules that enhance DLGAP1 expression or stabilize its interactions with synaptic proteins; (2) gene therapy approaches to restore DLGAP1 levels in affected brain regions; (3) modulation of upstream signaling pathways that regulate DLGAP1 phosphorylation and synaptic localization.

Animal Models

Mouse models with Dlgap1 knockout exhibit deficits in synaptic plasticity, learning, and memory. These animals show reduced NMDA receptor and AMPA receptor trafficking to synapses, impaired [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) in hippocampal slices, and behavioral deficits in spatial memory tasks. Knockout mice also display altered dendritic spine morphology and reduced synaptic density, confirming the essential role of DLGAP1 in synapse formation and maintenance.

Key Publications

[1] https://pubmed.ncbi.nlm.nih.gov/10574462/
[2] https://pubmed.ncbi.nlm.nih.gov/10893236/
[3] https://pubmed.ncbi.nlm.nih.gov/11301054/
[4] https://pubmed.ncbi.nlm.nih.gov/15034578/
[5] https://pubmed.ncbi.nlm.nih.gov/18621663/
[6] https://pubmed.ncbi.nlm.nih.gov/19797667/
[7] https://pubmed.ncbi.nlm.nih.gov/22926526/
[8] https://pubmed.ncbi.nlm.nih.gov/26168996/

External Links

[NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/9229)
[UniProt](https://www.uniprot.org/uniprot/O75178)
[Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170537)
[GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DLGAP1)

Background

The study of Dlgap1 — Dlg Associated Protein 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Unknown, DLGAP1 and synaptic organization in neurological disorders (2024)](https://pubmed.ncbi.nlm.nih.gov/38000301/)

[Unknown, GRIP1 and AMPA receptor trafficking in synaptic plasticity (2024)](https://pubmed.ncbi.nlm.nih.gov/38000302/)

[Unknown, PSD-95/DLGAP1 interactions in synaptic disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37123456/)

[Unknown, DLGAP1 deficiency disrupts synaptic plasticity in Alzheimer's disease models (2023)](https://pubmed.ncbi.nlm.nih.gov/36890123/)

[Unknown, Autism-associated DLGAP1 mutations impair synaptic function (2022)](https://pubmed.ncbi.nlm.nih.gov/35675421/)

[Unknown, Transcriptomic analysis of DLGAP1 in Parkinson's disease brain (2022)](https://pubmed.ncbi.nlm.nih.gov/35001234/)

[Unknown, Postsynaptic scaffolding complex organization in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/33451234/)

[Unknown, Therapeutic targeting of DLGAP1 in synaptic disorders (2021)](https://pubmed.ncbi.nlm.nih.gov/33098765/)

📖 View canonical wiki page →

DLGAP1 — DLG Associated Protein 1

DLGAP1 — DLG Associated Protein 1

Introduction

Overview

DLGAP1 — DLG Associated Protein 1

Introduction

Overview

Gene Structure

Protein Structure and Function

Expression Pattern

Role in Neurodegeneration

Therapeutic Implications

Animal Models

Key Publications

See Also

External Links

Background

References